Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Non-Muscle Invasive Bladder Carcinoma”

107 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 107 results

Large-scale testing (Phase 3)Study completedNCT07279792
What this trial is testing

Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNonmuscle Invasive Bladder CancerIrrigation+3 more
Ain Shams University 150
Large-scale testing (Phase 3)Study completedNCT00003814
What this trial is testing

Eflornithine in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
National Cancer Institute (NCI) 450
Not applicableLooking for participantsNCT06991868
What this trial is testing

Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)

Who this might be right for
NMIBCMIBCUTUC
Peking University First Hospital 300
Not applicableActive Not RecruitingNCT07511517
What this trial is testing

BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder NeoplasmsUrinary Bladder NeoplasmsCarcinoma, Transitional Cell, Bladder
Oslo University Hospital 500
Post-approval studies (Phase 4)Looking for participantsNCT06781879
What this trial is testing

Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Jakob Kristian Jakobsen 272
Testing effectiveness (Phase 2)Study completedNCT03914794
What this trial is testing

Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

Who this might be right for
Bladder CancerNMIBCNon-Muscle Invasive Bladder Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Early research (Phase 1)Looking for participantsNCT06766266
What this trial is testing

Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment

Who this might be right for
Non-Muscle Invasive Bladder Urothelial Carcinoma
First Affiliated Hospital of Chongqing Medical University 18
Large-scale testing (Phase 3)UnknownNCT01094964
What this trial is testing

Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

Who this might be right for
Bladder Cancer
Cancer Research Campaign Clinical Trials Centre 242
Very early researchStudy completedNCT00734994
What this trial is testing

Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer

Who this might be right for
Transitional Cell Carcinoma of BladderSuperficial Bladder Cancer
Mark Dewhirst 15
Not applicableStudy completedNCT03962933
What this trial is testing

Urine-based Detection of Non-muscle Invasive Bladder

Who this might be right for
Bladder Cancer
Nessn Azawi 196
Large-scale testing (Phase 3)Looking for participantsNCT05037279
What this trial is testing

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)

Who this might be right for
Bladder CancerBladder Cancer RecurrentNeoplasm Recurrence+3 more
Verity Pharmaceuticals Inc. 540
Large-scale testing (Phase 3)Study completedNCT00006124
What this trial is testing

Celecoxib in Treating Patients With Bladder Cancer

Who this might be right for
Recurrent Bladder Cancer
National Cancer Institute (NCI) 152
Large-scale testing (Phase 3)Not Yet RecruitingNCT07464145
What this trial is testing

NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerBladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Urothelial Carcinoma Bladder+2 more
Relmada Therapeutics, Inc. 393
Not applicableUnknownNCT04298073
What this trial is testing

Skipping BCG for T1a Urinary Bladder Tumor.

Who this might be right for
Superficial Bladder Cancer t1a
Assiut University 43
Large-scale testing (Phase 3)WithdrawnNCT01284205
What this trial is testing

First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC

Who this might be right for
Bladder Cancer
Bioniche Life Sciences Inc.
Not applicableUnknownNCT04664816
What this trial is testing

Omega-3 Polyunsaturated Fatty Acids and Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Cancer
Mansoura University 110
Early research (Phase 1)Study completedNCT02808143
What this trial is testing

Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Recurrent Bladder CarcinomaStage 0a Bladder Urothelial CarcinomaStage 0is Bladder Urothelial Carcinoma+1 more
Northwestern University 9
Not applicableUnknownNCT05146635
What this trial is testing

Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial

Who this might be right for
Bladder Cancer
Mansoura University 110
Early research (Phase 1)Looking for participantsNCT06173349
What this trial is testing

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

Who this might be right for
Recurrent Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more
University of California, Davis 12
Testing effectiveness (Phase 2)UnknownNCT04671407
What this trial is testing

The Aim of This Study is to Compare the Efficacy of Perioperative Hypertonic Saline 3% Versus Normal Saline (0.9%) in Decreasing Recurrence Risk in Non-muscle Invasive Bladder Cancer

Who this might be right for
TCC
Kaplan Medical Center 150
Load More Results